Publications by authors named "Bret D Perry"

Claim this Profile
D
Discovery of CP-690,550: a potent and selective Janus kinase (JAK) inhibitor for the treatment of autoimmune diseases and organ transplant rejection.
Mark E Flanagan, Todd A Blumenkopf, William H Brissette, Matthew F Brown, Jeffrey M Casavant, Bret D Perry, Perry S Sawyer

J Med Chem· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCR2 receptor blockade alters blood monocyte subpopulations but does not affect atherosclerotic lesions in apoE(-/-) mice.
Robert J Aiello, Bret D Perry, Patricia-Ann Bourassa, Andrew Robertson, Weifan Weng

Atherosclerosis· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor.
Paul S Changelian, Mark E Flanagan, Douglas J Ball, Craig R Kent, Kelly S Magnuson, Perry S Sawyer, Bret D Perry

Science· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis